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Strengths and limitations of this study
 ► This is a core outcome set with a broad scope that 
will be widely applicable to children’s fractures and 
injuries.
 ► The core outcome set draws from experience from 
a wide range of stakeholders to ensure that the out-
comes selected are relevant.
 ► The scope of this study is to deliver an outcome set 
for children aged 5–15 for randomised trials. It may 
be applicable to all research studies and to infants 
and adolescents, but further work will be required 
to confirm this.
AbStrACt
Introduction Limb fractures in children are common yet 
there are few trials that compare treatments for these 
injuries. There is significant heterogeneity in the outcomes 
reported in the paediatric orthopaedic literature, which 
limits the ability to compare study results and draw 
firm conclusions. The aim of the CORE- Kids Study is to 
develop a core outcome set for use in research studies of 
childhood limb fractures. A core outcome set will provide 
a minimum set of outcomes to be measured in all trials 
to minimise the heterogeneity of outcomes reported and 
minimise reporting bias. A core outcome set ensures that 
outcomes are reported that are relevant to families as well 
as clinicians. The core outcome set will include additional 
upper and lower limb modules.
Methods The development of the core outcome set will 
require four phases to evaluate:
1. What are the outcomes that are relevant to 
professionals?
2. What are the outcomes that are relevant to families?
3. What are the most important of these outcomes?
4. Which outcomes should be included in the core 
outcome set?
This will be completed through a systematic review of 
trials to identify the outcomes domains that are relevant 
to trialists. A series of semi- structured interviews will be 
completed with families to identify the outcome domains 
that are relevant to families. These outcome domains 
will be used in a three- round Delphi Study to analyse 
the importance of these outcome domains to a range of 
stakeholders including parents, clinicians and researchers. 
Following this, the core outcome set will be decided at a 
consensus meeting.
Ethics and dissemination Ethical approval has been 
awarded HRA/REC IRAS number 262503. Date of approval 
06/08/2019. Dissemination will be through scientific 
literature and international societies.
trial registration Core Outcome Measures in 
Effectiveness Trials Initiative, registration number: 1274. 
Date of registration 13/12/2018.
PrOSPErO registration number CRD42018106605.
IntrOduCtIOn
The WHO and UNICEF have identified child-
hood injury as a leading cause of mortality 
and morbidity in low and middle income 
countries.1 The precise global burden of 
childhood fractures is not known, but 1 in 3 
children in Europe will sustain a fracture by 
their 17th birthday.2
There are six Cochrane reviews that have 
evaluated the literature supporting the 
management of childhood fractures.3–8 The 
reviews have identified 45 trials with sufficient 
quality to inform practice, with most trials 
relating to the management of wrist frac-
tures. Only two reviews were able to draw firm 
conclusions due to a paucity of randomised 
trials in children’s fracture care, despite the 
relative high frequency of these injuries.5 7
There is a need to deliver high quality 
randomised trials to evaluate treatments in 
childhood fractures, and these trials need 
to be underpinned by a robust rationale 
for the selection of primary and secondary 
outcomes.9–11 There is a growing use of 
patient reported outcomes in paediatric 
orthopaedics with little agreement regarding 
the selection of outcome tools to compare 
treatments.12 13
To compare treatments or interventions, 
an outcome needs to be identified which 
encompasses a feature of the condition to 
measure and a technique to measure it. An 
outcome domain is the broad feature of the 
condition or a patient’s health that is being 
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function), whereas the outcome tool is the technique 
used to measure it.14
The heterogeneity of reporting of outcomes can 
be improved through the development and adoption 
of a core outcome set.15 16 This is an agreed minimum 
standard group of outcomes that are reported in every 
research study.17 Through using a core set and adding 
any additional relevant secondary outcomes, trialists can 
ensure that their results are relevant to surgeons, families 
and other stakeholders and can be effectively combined 
for evidence synthesis and guideline generation.14
The Core Outcome Measures in Effectiveness Trials 
(COMET) Initiative is an international collaboration with 
the objective of promoting the development and use of 
core outcome sets. The COMET Initiative has published a 
handbook evaluating the available methodology for devel-
oping a core outcome set18 and reporting standards for 
the development and reporting of core outcome sets.19 20
There are only a few core outcome sets that have been 
developed for use in orthopaedic trials.21 For trials relating 
to fractures, the only core outcome set available has been 
developed for trials of hip fractures in the elderly which 
would not be appropriate to extrapolate onto fractures 
in children.22 A core outcome set is in development for 
medial epicondyle fractures in children, but this is a rela-
tively uncommon injury and is focussed on a single frac-
ture type.23
The CORE- Kids Study will develop a core outcome set 
identifying the core domains that should be measured in 
every trial of childhood fractures. This protocol has been 
devised in line with the Core Outcome Set- STAndard 
Protocol Items (COS-STAP) statement24 and the devel-
opment studies will be completed and reported as per 
the Core Outcome Set- Standadards for development 
(COS-STAD) and Core Outcome Set- Standadards for 
reporting (COS-STAR) statements.19 20
Study scope
The scope for this core outcome set has been set by the 
steering group in conjunction with the National Institute 
for Health Research Trauma Trials network.
The scope for this core outcome set is:
 ► Setting: research studies.
 ► Health condition: fractures to the appendicular skel-
eton (ie, limbs, pelvis, shoulder girdle but not spine, 
ribs or head) excluding children with multiple inju-
ries. The core outcome set will be divided into three 
modules: a central ‘all fractures’ set, an ‘upper limb’ 
set and a ‘lower limb’ set.
 ► Target population: school aged children (aged 
5–16)—it is anticipated that infants (0–4) and 
older adolescents (17–18) may share common core 
outcomes but this cannot be assumed and should be 
confirmed in future work.
 ► Target interventions: treatment for fractures, both 
involving surgical and non- surgical (conservative) 
techniques.
MEthOdS And dESIgn
The development of the core outcome set will require 
four phases to evaluate:
 ► What are the outcomes that are relevant to trialists?
 ► What are the outcomes that are relevant to families?
 ► What are the most important of these outcomes?
 ► Which outcomes should be included in the core 
outcome set?
These questions will be answered sequentially through 
a systematic review of trials, interviews with families, 
an international online Delphi Study and a consensus 
meeting.
What are the outcomes that are relevant to professionals?
In order to understand the outcomes most relevant to 
professionals, a systematic review of all trials in childhood 
fractures will be completed. This systematic review will 
identify all outcomes that have been reported in trials 
relating to childhood fractures. The review has been 
prospectively registered in the PROSPERO database25 and 
will be reported according to Preferred Reporting Items 
for Systematic Reviews and Meta- Analyses statement.26
Studies that are randomised or quasi- randomised will 
be included where the majority of the participants are 
children (age <16) who have sustained fractures to the 
appendicular skeleton or dislocations to large joints. All 
interventions that are designed to treat fractures will be 
considered, with the exclusion of studies that evaluate the 
efficacy of anaesthetic or analgesia techniques in isola-
tion. Study protocols and trial registrations of randomised 
or quasi- randomised trials will also be included where 
outcomes are identified.
English language interventional trials of childhood 
fractures will be identified by searching electronic data-
base, reviewing bibliographies of Cochrane reviews and 
hand searching of trial registries and online search 
engines. The electronic databases that will be searched 
are OVID MEDLINE, OVID Embase and the Cochrane 
Central Register of Controlled Trial. A manual search of 
clinicaltrials. gov, the International Standard Randomised 
Controlled Trial Number (ISRCTN) registry and WHO 
International Clinical Trials Registry Platform (ICTRP) 
will be completed to identify any unpublished or in- prog-
ress trials.
Titles will be screened by one researcher and full texts 
analysed by two researchers. Outcomes and outcome 
tools will be extracted and classified according to the 
WHO International classification of functioning (WHO 
ICF).27
No formal assessment of study quality or risk of bias will 
be completed as the objective of this review is to iden-
tify outcomes reported in trials rather than prioritise 
outcomes or evaluate treatment options. Therefore, the 
quality of each study will not add any additional value to 
this review. This is consistent with other systematic review 
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What are the outcomes that are relevant to families?
The outcomes that are relevant to families will be evalu-
ated through a series of semi- structured interviews with 
parent–child dyads (composed of the child and at least 
one parent or carer) where the child has recent experi-
ence of breaking a bone in the appendicular skeleton. 
The use of semi- structured interview design has been 
selected to maximise the depth of the data that will be 
obtained while ensuring that different domains within 
the WHO ICF are covered. Interviews will be completed 
in the fracture clinic as a familiar environment following 
the child’s final clinical review.31 32
Interviews will be conducted by a PhD research student 
with supervision from an expert in children’s qualitative 
research. The PhD student will receive training in inter-
view skills and analysis techniques prior to completing 
these aspects of the study.
The sample size has been set to achieve data saturation. 
A target of 20 interviews will be conducted with parent–
child dyads. Parent–child dyads have been selected to 
provide a familiar adult for the child, to allow the child 
to express their opinions and obtain the combined 
experience of parents and children.31 33 34 Sample size 
has been determined as a minimum required to achieve 
saturation after consideration of the scope of identi-
fying outcomes and that the nature of the topic involves 
discussing issues that are not sensitive or distressing.35
Heterogeneous, purposeful sampling will be applied 
to achieve a mix of families with children of different 
genders, fracture sites (upper and lower limb), fracture 
severity (inpatient or outpatient treatment) and expe-
rience of surgery and experience of cast treatment.36 
Families will be invited to volunteer and participate 
through posters in the clinic.
A semi- structured interview schedule has been devel-
oped based on the recommendations of Selb et al.37 The 
schedule has been modified following pilot testing with 
a parent involvement group of families. Interviews will 
be recorded and transcribed.
As advocated in the literature, art- based approaches 
(draw and tell, graphic elicitation) will be used to facil-
itate the involvement and verbal responses from child 
participants.38 39 The focus of the semi- structured inter-
views will be on exploring the following areas: (1) expe-
rience of injury; (2) frustrations of recovering and (3) 
features of recovery and positive and negative outcomes.
A content analysis will be performed to identify the 
outcome domains that are identified by parents and 
children that are relevant to them during the experi-
ence of injury and recovery. The outcome domains 
will be classified according to the WHO ICF based on 
the linking rules by Cieza et al to maintain consistency 
with the outcomes that are relevant to trialists identi-
fied during the systematic review.40 41 Coding for the 
content analysis will be performed by two researchers 
and a saturation table completed using the identified 
WHO ICF domains to ensure that saturation is achieved 
prior to completion of the study.
The findings from these interviews will be combined 
with the results of the systematic review to draw a long 
list of outcome domains for evaluation using consensus 
methodology.
What are the most important of these outcomes?
The long list of candidate outcomes will be reduced 
through an international three- round Delphi Survey 
involving relevant stakeholders. As a method of devel-
oping consensus, the Delphi technique involves 
obtaining successive scores for each outcome from each 
expert panellist following feedback over multiple survey 
rounds.42 43
The Delphi Survey has been designed so that each 
outcome domain will be evaluated twice: once for impor-
tance for upper limb trials and once for lower limb trials. 
All outcomes will be reviewed by our patent participation 
group to ensure comprehensibility by lay panellists as well 
as professionals.
A three- round design has been selected to maximise 
the chance of delivering consensus, while minimising 
the attrition bias that the survey is exposed to if too many 
rounds are undertaken. In the general medical litera-
ture and in the developments of core outcome sets, the 
median and upper quartile number of rounds completed 
is three rounds,44 45 with only 6% of Delphi studies used to 
agree importance of outcomes incorporating more than 
three rounds.46
As no feedback mechanism has been proven to be 
most effective in generating consensus,47 we will provide 
multiple- combined feedback from all groups to mini-
mise the number of results that need to be interpreted 
by panellists.
The Delphi Study will be completed as an online survey 
using the  onlinesurveys. ac. uk interface (JISC, Bristol, 
UK). Panellists will be assigned a unique code to access 
the online survey system to permit monitoring of survey 
completion and attrition. All panellists will be sent up to 
four email reminders of survey deadlines to maximise 
completion.
Expert panellists will be approached to represent the 
following stakeholder groups:
 ► Parents of children who have had a broken bone.
 ► Doctors or surgeons who treat children with broken 
bones.
 ► Paediatric nurses and therapists.
 ► Teachers.
 ► Researchers who have been involved with studies for 
children with broken bones.
 ► Systematic reviewers who have been involved with 
reviews of studies for children with broken bones.
Panellists will be assigned a unique code to access 
the online survey system to permit recording of survey 
completion and attrition. All panellists will be sent e- mail 
reminders of survey deadlines to maximise completion.
For each outcome domain, panellists will assign scores 
from 1 to 9 (very important) using a Likert Scale. Each 
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Figure 1 Study flow chart for the three- round Delphi Study. Outcome domains will be identified as ‘consensus in’ if 70% 
of panellists rate the outcome domain with a score of 7–9 and fewer than 15% of panellists score the domain 1–3. Outcome 
domains will be identified as ‘consensus out’ if 70% of panellists score the outcome domain 1–3 and fewer than 15% of 
panellists score the domain 7–9.
once for upper limb and once for lower limb fractures. 
In subsequent rounds, outcome domains may be scored 
once or twice, depending if consensus has been reached.
In order to minimise the attrition bias associated with 
Delphi Surveys with higher numbers of items,46 outcome 
domains will be removed from the second and third 
rounds if consensus is reached. Outcome domains will 
be removed from further Delphi rounds if consensus 
in (>70% panellists ranking an outcome with a score of 
7–9 and fewer than 15% scoring the outcome 1–3) or 
consensus out (>70% panellists ranking an outcome with 
a score of 1–3 and fewer than 15% scoring the outcome 
7–9) is achieved (figure 1). This consensus threshold 
has been selected as it is consistent with previous meth-
odology for the development of core outcome sets48–50 
and ensures that outcome domains are only retained or 
exclude if there is a significant majority voting in favour 
with a small minority expressing the opposite opinion.17
No sample size calculations may be performed to guide 
the panel size for this Delphi. As a target, 75–100 panellists 
will be recruited to permit for attrition between rounds 
and to ensure that each stakeholder group has repre-
sentation.18 The stakeholder groups will be pooled into 
a single panel for completion of the Delphi Survey and 
in the preparation of feedback between survey rounds. 
This is to minimise the research burden on panellists 
and to maximise the likelihood of reaching consensus.18 
A key potential concern with this methodology is that it 
is possible for the opinion of minority key stakeholder 
groups to be overwhelmed if the stakeholder balance is 
not controlled. To prevent this situation, three key stake-
holder groups (1. doctors and researchers; 2. nurses and 
therapists and 3. parents) will each contribute to a target 
minimum of 20% of the total participants in the panel.
During the first round of Delphi, panellists will be 
invited to contribute any additional relevant outcomes 
that have not been captured in the systematic review or 
qualitative interviews for inclusion in the second- round 
survey. Outcome domains that are consensus in or remain 
following the three rounds of Delphi will be included in 
the consensus meeting for consideration for the core 
outcome set.
Additional outcomes that are suggested in the first- 
round survey will be coded by two researchers to ensure 
that it represents a new outcome. Where there is disagree-
ment between the two researchers, the senior author will 
be given a casting vote. New outcomes will be introduced 
into the Delphi Survey during the second round.
At second and third rounds of the Delphi Survey, panel-
lists will be provided with median scores for the whole 
group and a graphical representation of the score and 
interquartile ranges. Individual stakeholder group sub- 
group analysis will not be performed here but will be 
performed and provided to participants in the consensus 
meeting. All panellists that submit a full or partial 
response will be invited to contribute to the next round.
Which outcomes should be included in the core outcome set?
The outputs from the three preceding studies will be eval-
uated at a face to face consensus meeting to develop the 
core outcome set for use in trials of childhood fractures. 
The consensus meeting will follow an iterative method-
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Figure 2 Study flow for consensus meeting. Important outcomes will be identified through voting following each breakout 
session. Important outcomes will then be ranked and further voting will be completed to identify the outcomes for inclusion in 
the core outcome set.
sets as reported by Selb et al.37 The study flow chart is 
shown in figure 2.
The objective of the meeting will be to identify the 
most important outcome domains for inclusion I the 
core outcome set and to develop recommendations for 
the core outcome set with additional upper and lower 
limb modules. Expert participants will be approached to 
represent the following stakeholder groups:
 ► Parents of children who have had a broken bone.
 ► Doctors or surgeons who treat children with broken 
bones.
 ► Paediatric nurses and therapists.
 ► Teachers.
 ► Researchers who have been involved with studies for 
children with broken bones.
 ► Systematic reviewers who have been involved with 
reviews of studies for children with broken bones.
A minimum of 24 participants will be involved in voting 
and deciding on the outcome set to permit breakout 
sessions of 7 participants for facilitated discussion of each 
outcome domain.
Participants will be provided with an information pack 
summarising the findings from the first three phases 
of this study. An initial in/out screening vote on each 
outcome will be performed at the start of the meeting 
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discussion in the breakout sessions. Further voting will 
follow facilitated breakout sessions where remaining 
outcome domains will be evaluated and discussed. Voting 
will be performed using an electronic survey inter-
face to enable real time analysis and rapid feedback to 
participants.
At each voting round, outcome domains will be included 
or excluded if the consensus threshold of 70% is met. All 
remaining outcome domains will be discussed in facilitated 
breakout sessions. Two rounds of discussion are planned 
followed by majority voting to ensure that all outcome 
domains are categorised for further discussion or exclusion.
Once an important outcome domain set is derived, 
participants will score all outcome domains to produce 
a ranked list of outcomes for upper and lower limb frac-
tures. Voting will occur in order of outcome rank to iden-
tify those for the upper limb core set (>70% ‘Yes’). When 
30%–70% of participants vote ‘Yes’ the outcome domain 
will be identified as important, but not core. When 
>30% vote ‘No’ then the round will close, and the ranked 
voting will be repeated for lower limb outcome domains.
Outcome domains that are voted for inclusion in both 
the upper and lower limb core sets will form the generic 
fracture core set. Outcome domains voted for inclusion in 
the upper limb but not the lower limb core set will form 
the upper limb module and outcome domains voted for 
inclusion in the lower limb but not the upper limb core 
set will form the lower limb module.
dissemination
Study results will be presented at national and interna-
tional meetings and disseminated via peer- reviewed jour-
nals. Participants will be provided with a plain English 
summary of results and a statement will be placed on the 
Trauma Outcome Group’s website.
Patient and public involvement
Patients and parents have been actively involved in shaping 
this research as collaborators with the research team. Patient 
and public involvement has been maintained through all 
stages of development including defining research ques-
tion, trial design and selection of methodologies.
dISCuSSIOn
The CORE- Kids Study will develop a core outcome set for 
use in all trials relating to the management of fractures in 
children. The development of this core outcome set has 
been scoped to deliver a versatile set of outcomes, with 
additional modules for upper and lower limb fractures.
The core outcome set will make identification and 
justification of the selection of outcomes as primary and 
secondary outcomes easier for future trials and stan-
dardise reporting of new trials.
The CORE- Kids outcome set will need development in 
the future through selection of outcome tools to measure 
the outcome domains identified in the set. This will require 
an understanding of the measurement properties of 
outcome tools to guide selection and recommendation of 
the best tools to undertake measurements.51 This represents 
important further work that will compliment this study.
twitter Joseph C Manning @josephcmanning
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